Cargando…
Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial
IMPORTANCE: Limited evidence supports multigenetic pharmacogenomics–guided treatment (MPGT) in schizophrenia. OBJECTIVE: To evaluate the clinical effectiveness of MPGT in schizophrenia in a randomized clinical trial (RCT). DESIGN, SETTING, AND PARTICIPANTS: This RCT was conducted from March 2020 to...
Autores principales: | Kang, Zhewei, Qin, Ying, Sun, Yutao, Lu, Zhe, Sun, Yaoyao, Chen, Huan, Feng, Xiaoyang, Zhang, Yuyanan, Guo, Hua, Yan, Hao, Yue, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559185/ https://www.ncbi.nlm.nih.gov/pubmed/37801319 http://dx.doi.org/10.1001/jamanetworkopen.2023.35518 |
Ejemplares similares
-
Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis
por: Lu, Zhe, et al.
Publicado: (2022) -
Oxidative Stress and Psychiatric Disorders: Evidence from the Bidirectional Mendelian Randomization Study
por: Lu, Zhe, et al.
Publicado: (2022) -
Peripheral non-enzymatic antioxidants as biomarkers for mood disorders: Evidence from a machine learning prediction model
por: Gong, Yuandong, et al.
Publicado: (2022) -
A narrative review of five multigenetic assays in breast cancer
por: Zeng, Cheng, et al.
Publicado: (2022) -
Dissecting the causal association between social or physical inactivity and depression: a bidirectional two-sample Mendelian Randomization study
por: Zhao, Guorui, et al.
Publicado: (2023)